APO Research
Talk to an analyst

APO RESEARCH · REPORT

Telmisartan

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Telmisartan Industry Growth and Trends Forecast to 2032

26 December 2025102 pages

Choose your research edition.

Industry ResearchTelmisartan Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Telmisartan Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Telmisartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Telmisartan Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Telmisartan Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Telmisartan market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Telmisartan include Beijing Wansheng Pharmaceutical, Boehringer Ingelheim, Hema Pharmaceuticals Pvt, Nippon Boehringer Ingelheim, Reddy's Laboratories (UK), Astellas Pharma Inc, Bayer, GSK and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Telmisartan market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Telmisartan market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Telmisartan market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Telmisartan.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Telmisartan market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Telmisartan Market by Company

Beijing Wansheng Pharmaceutical

Boehringer Ingelheim

Hema Pharmaceuticals Pvt

Nippon Boehringer Ingelheim

Reddy's Laboratories (UK)

Astellas Pharma Inc

Bayer

GSK

Pfizer

Mylan

Novartis

Teva

Takeda

Abbott

Telmisartan Segment by Type

Injection

Freeze-Dried Powder

Telmisartan Segment by Application

Hospital

Clinic

Others

Telmisartan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telmisartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Telmisartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telmisartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Telmisartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Freeze-Dried Powder Table 3. Global Telmisartan Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Telmisartan Sales by Type (2021-2026) & (Tons) Table 5. Global Telmisartan Sales Market Share in Volume by Type (2021-2026) Table 6. Global Telmisartan Sales by Type (2021-2026) & (US$ Million) Table 7. Global Telmisartan Sales Market Share in Value by Type (2021-2026) Table 8. Global Telmisartan Price by Type (2021-2026) & (US$/Kg) Table 9. Global Telmisartan Sales by Type (2027-2032) & (Tons) Table 10. Global Telmisartan Sales Market Share in Volume by Type (2027-2032) Table 11. Global Telmisartan Sales by Type (2027-2032) & (US$ Million) Table 12. Global Telmisartan Sales Market Share in Value by Type (2027-2032) Table 13. Global Telmisartan Price by Type (2027-2032) & (US$/Kg) Table 14. North America Telmisartan Sales by Type (2021-2026) & (Tons) Table 15. North America Telmisartan Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Telmisartan Sales by Type (2021-2026) & (Tons) Table 17. Europe Telmisartan Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Telmisartan Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Telmisartan Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Telmisartan Sales by Type (2021-2026) & (Tons) Table 21. Latin America Telmisartan Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Telmisartan Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Telmisartan Sales by Type (2021-2026) & (US$ Million) Table 24. Telmisartan Industry Trends Table 25. Telmisartan Industry Drivers Table 26. Telmisartan Industry Opportunities and Challenges Table 27. Telmisartan Industry Restraints Table 28. Global Telmisartan Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Telmisartan Revenue Market Share by Company (2021-2026) Table 30. Global Telmisartan Sales by Company (2021-2026) & (Tons) Table 31. Global Telmisartan Sales Share by Company (2021-2026) Table 32. Global Telmisartan Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Telmisartan Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Telmisartan Major Company Production Sites and Headquarters Table 35. Global Telmisartan Company, Product Type & Application Table 36. Global Telmisartan Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Telmisartan by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Telmisartan Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Telmisartan Sales by Region (2021-2026) & (Tons) Table 41. Global Telmisartan Sales Market Share in Volume by Region (2021-2026) Table 42. Global Telmisartan Sales by Region (2021-2026) & (US$ Million) Table 43. Global Telmisartan Sales Market Share in Value by Region (2021-2026) Table 44. Global Telmisartan Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Telmisartan Sales by Region (2027-2032) & (Tons) Table 46. Global Telmisartan Sales Market Share in Volume by Region (2027-2032) Table 47. Global Telmisartan Sales by Region (2027-2032) & (US$ Million) Table 48. Global Telmisartan Sales Market Share in Value by Region (2027-2032) Table 49. Global Telmisartan Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Telmisartan Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Telmisartan Sales by Application (2021-2026) & (Tons) Table 52. Global Telmisartan Sales Market Share in Volume by Application (2021-2026) Table 53. Global Telmisartan Sales by Application (2021-2026) & (US$ Million) Table 54. Global Telmisartan Sales Market Share in Value by Application (2021-2026) Table 55. Global Telmisartan Price by Application (2021-2026) & (US$/Kg) Table 56. Global Telmisartan Sales by Application (2027-2032) & (Tons) Table 57. Global Telmisartan Sales Market Share in Volume by Application (2027-2032) Table 58. Global Telmisartan Sales by Application (2027-2032) & (US$ Million) Table 59. Global Telmisartan Sales Market Share in Value by Application (2027-2032) Table 60. Global Telmisartan Price by Application (2027-2032) & (US$/Kg) Table 61. North America Telmisartan Sales by Application (2021-2026) & (Tons) Table 62. North America Telmisartan Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Telmisartan Sales by Application (2021-2026) & (Tons) Table 64. Europe Telmisartan Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Telmisartan Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Telmisartan Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Telmisartan Sales by Application (2021-2026) & (Tons) Table 68. Latin America Telmisartan Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Telmisartan Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Telmisartan Sales by Application (2021-2026) & (US$ Million) Table 71. Beijing Wansheng Pharmaceutical Company Information Table 72. Beijing Wansheng Pharmaceutical Business Overview Table 73. Beijing Wansheng Pharmaceutical Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio Table 75. Beijing Wansheng Pharmaceutical Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Telmisartan Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Hema Pharmaceuticals Pvt Company Information Table 82. Hema Pharmaceuticals Pvt Business Overview Table 83. Hema Pharmaceuticals Pvt Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Hema Pharmaceuticals Pvt Telmisartan Product Portfolio Table 85. Hema Pharmaceuticals Pvt Recent Development Table 86. Nippon Boehringer Ingelheim Company Information Table 87. Nippon Boehringer Ingelheim Business Overview Table 88. Nippon Boehringer Ingelheim Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Nippon Boehringer Ingelheim Telmisartan Product Portfolio Table 90. Nippon Boehringer Ingelheim Recent Development Table 91. Reddy's Laboratories (UK) Company Information Table 92. Reddy's Laboratories (UK) Business Overview Table 93. Reddy's Laboratories (UK) Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Reddy's Laboratories (UK) Telmisartan Product Portfolio Table 95. Reddy's Laboratories (UK) Recent Development Table 96. Astellas Pharma Inc Company Information Table 97. Astellas Pharma Inc Business Overview Table 98. Astellas Pharma Inc Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Astellas Pharma Inc Telmisartan Product Portfolio Table 100. Astellas Pharma Inc Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Bayer Telmisartan Product Portfolio Table 105. Bayer Recent Development Table 106. GSK Company Information Table 107. GSK Business Overview Table 108. GSK Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. GSK Telmisartan Product Portfolio Table 110. GSK Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Pfizer Telmisartan Product Portfolio Table 115. Pfizer Recent Development Table 116. Mylan Company Information Table 117. Mylan Business Overview Table 118. Mylan Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Mylan Telmisartan Product Portfolio Table 120. Mylan Recent Development Table 121. Novartis Company Information Table 122. Novartis Business Overview Table 123. Novartis Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Novartis Telmisartan Product Portfolio Table 125. Novartis Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Teva Telmisartan Product Portfolio Table 130. Teva Recent Development Table 131. Takeda Company Information Table 132. Takeda Business Overview Table 133. Takeda Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. Takeda Telmisartan Product Portfolio Table 135. Takeda Recent Development Table 136. Abbott Company Information Table 137. Abbott Business Overview Table 138. Abbott Telmisartan Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 139. Abbott Telmisartan Product Portfolio Table 140. Abbott Recent Development Table 141. North America Telmisartan Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. North America Telmisartan Sales by Country (2021-2026) & (Tons) Table 143. North America Telmisartan Sales Market Share by Country (2021-2026) Table 144. North America Telmisartan Sales Forecast by Country (2027-2032) & (Tons) Table 145. North America Telmisartan Sales Market Share Forecast by Country (2027-2032) Table 146. North America Telmisartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Telmisartan Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Telmisartan Market Share by Country (2021-2026) Table 149. North America Telmisartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Telmisartan Market Share Forecast by Country (2027-2032) Table 151. Europe Telmisartan Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Europe Telmisartan Sales by Country (2021-2026) & (Tons) Table 153. Europe Telmisartan Sales Market Share by Country (2021-2026) Table 154. Europe Telmisartan Sales Forecast by Country (2027-2032) & (Tons) Table 155. Europe Telmisartan Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Telmisartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Telmisartan Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Telmisartan Market Share by Country (2021-2026) Table 159. Europe Telmisartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Telmisartan Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Telmisartan Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Telmisartan Sales by Country (2021-2026) & (Tons) Table 163. Asia-Pacific Telmisartan Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Telmisartan Sales Forecast by Country (2027-2032) & (Tons) Table 165. Asia-Pacific Telmisartan Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Telmisartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Telmisartan Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Telmisartan Market Share by Country (2021-2026) Table 169. Asia-Pacific Telmisartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Telmisartan Market Share Forecast by Country (2027-2032) Table 171. Latin America Telmisartan Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 172. Latin America Telmisartan Sales by Country (2021-2026) & (Tons) Table 173. Latin America Telmisartan Sales Market Share by Country (2021-2026) Table 174. Latin America Telmisartan Sales Forecast by Country (2027-2032) & (Tons) Table 175. Latin America Telmisartan Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Telmisartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Telmisartan Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Telmisartan Market Share by Country (2021-2026) Table 179. Latin America Telmisartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Telmisartan Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Telmisartan Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Telmisartan Sales by Country (2021-2026) & (Tons) Table 183. Middle East and Africa Telmisartan Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Telmisartan Sales Forecast by Country (2027-2032) & (Tons) Table 185. Middle East and Africa Telmisartan Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Telmisartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Telmisartan Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Telmisartan Market Share by Country (2021-2026) Table 189. Middle East and Africa Telmisartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Telmisartan Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Telmisartan Distributors List Table 194. Telmisartan Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Telmisartan Image Figure 2. Global Telmisartan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Telmisartan Market Size (2021-2032) & (US$ Million) Figure 4. Global Telmisartan Sales (2021-2032) & (Tons) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (Tons) Figure 7. Freeze-Dried Powder Image Figure 8. Global Freeze-Dried Powder Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Telmisartan Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Telmisartan Market Share by Type 2025 VS 2032 Figure 11. North America Telmisartan Sales Market Share in Volume by Type in 2025 Figure 12. North America Telmisartan Sales Market Share in Value by Type in 2025 Figure 13. Europe Telmisartan Sales Market Share in Volume by Type in 2025 Figure 14. Europe Telmisartan Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Telmisartan Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Telmisartan Sales Market Share in Value by Type in 2025 Figure 17. Latin America Telmisartan Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Telmisartan Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Telmisartan Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Telmisartan Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Telmisartan Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Telmisartan Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Telmisartan Market Share by Application 2025 VS 2032 Figure 31. North America Telmisartan Sales Market Share in Volume by Application in 2025 Figure 32. North America Telmisartan Sales Market Share in Value by Application in 2025 Figure 33. Europe Telmisartan Sales Market Share in Volume by Application in 2025 Figure 34. Europe Telmisartan Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Telmisartan Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Telmisartan Sales Market Share in Value by Application in 2025 Figure 37. Latin America Telmisartan Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Telmisartan Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Telmisartan Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Telmisartan Sales Market Share in Value by Application in 2025 Figure 41. North America Telmisartan Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Telmisartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Telmisartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Telmisartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Telmisartan Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Telmisartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Telmisartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Telmisartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Telmisartan Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Telmisartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Telmisartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Telmisartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Telmisartan Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Telmisartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Telmisartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Telmisartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Telmisartan Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Telmisartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Telmisartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Telmisartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Telmisartan Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Telmisartan Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-Dried Powder
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Beijing Wansheng Pharmaceutical
  • Boehringer Ingelheim
  • Hema Pharmaceuticals Pvt
  • Nippon Boehringer Ingelheim
  • Reddy's Laboratories (UK)
  • Astellas Pharma Inc
  • Bayer
  • GSK
  • Pfizer
  • Mylan
  • Novartis
  • Teva
  • Takeda
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Telmisartan Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Telmisartan Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Telmisartan Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Freeze-Dried Powder
  8. 1.4 Global Telmisartan Market Size by Type
  9. 1.4.1 Global Telmisartan Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Telmisartan Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Telmisartan Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Telmisartan Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Telmisartan Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Telmisartan Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Telmisartan Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Telmisartan Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Telmisartan Industry Trends
  2. 2.2 Telmisartan Industry Drivers
  3. 2.3 Telmisartan Industry Opportunities and Challenges
  4. 2.4 Telmisartan Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Telmisartan Revenue (2021-2026)
  2. 3.2 Global Top Players by Telmisartan Sales (2021-2026)
  3. 3.3 Global Top Players by Telmisartan Price (2021-2026)
  4. 3.4 Global Telmisartan Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Telmisartan Major Company Production Sites & Headquarters
  6. 3.6 Global Telmisartan Company, Product Type & Application
  7. 3.7 Global Telmisartan Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Telmisartan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Telmisartan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Telmisartan Tier 1, Tier 2, and Tier 3
4 Telmisartan Regional Status and Outlook
  1. 4.1 Global Telmisartan Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Telmisartan Historic Market Size by Region
  3. 4.2.1 Global Telmisartan Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Telmisartan Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Telmisartan Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Telmisartan Forecasted Market Size by Region
  7. 4.3.1 Global Telmisartan Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Telmisartan Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Telmisartan Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Telmisartan by Application
  1. 5.1 Telmisartan Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Telmisartan Market Size by Application
  6. 5.2.1 Global Telmisartan Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Telmisartan Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Telmisartan Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Telmisartan Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Telmisartan Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Telmisartan Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Telmisartan Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Telmisartan Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Beijing Wansheng Pharmaceutical
  2. 6.1.1 Beijing Wansheng Pharmaceutical Company Information
  3. 6.1.2 Beijing Wansheng Pharmaceutical Business Overview
  4. 6.1.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
  6. 6.1.5 Beijing Wansheng Pharmaceutical Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Telmisartan Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Hema Pharmaceuticals Pvt
  14. 6.3.1 Hema Pharmaceuticals Pvt Company Information
  15. 6.3.2 Hema Pharmaceuticals Pvt Business Overview
  16. 6.3.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
  18. 6.3.5 Hema Pharmaceuticals Pvt Recent Developments
  19. 6.4 Nippon Boehringer Ingelheim
  20. 6.4.1 Nippon Boehringer Ingelheim Company Information
  21. 6.4.2 Nippon Boehringer Ingelheim Business Overview
  22. 6.4.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
  24. 6.4.5 Nippon Boehringer Ingelheim Recent Developments
  25. 6.5 Reddy's Laboratories (UK)
  26. 6.5.1 Reddy's Laboratories (UK) Company Information
  27. 6.5.2 Reddy's Laboratories (UK) Business Overview
  28. 6.5.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
  30. 6.5.5 Reddy's Laboratories (UK) Recent Developments
  31. 6.6 Astellas Pharma Inc
  32. 6.6.1 Astellas Pharma Inc Company Information
  33. 6.6.2 Astellas Pharma Inc Business Overview
  34. 6.6.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Astellas Pharma Inc Telmisartan Product Portfolio
  36. 6.6.5 Astellas Pharma Inc Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Telmisartan Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Telmisartan Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Telmisartan Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Telmisartan Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novartis Telmisartan Product Portfolio
  66. 6.11.5 Novartis Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Telmisartan Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 Takeda
  74. 6.13.1 Takeda Company Information
  75. 6.13.2 Takeda Business Overview
  76. 6.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Telmisartan Product Portfolio
  78. 6.13.5 Takeda Recent Developments
  79. 6.14 Abbott
  80. 6.14.1 Abbott Company Information
  81. 6.14.2 Abbott Business Overview
  82. 6.14.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abbott Telmisartan Product Portfolio
  84. 6.14.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Telmisartan Sales by Country
  2. 7.1.1 North America Telmisartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Telmisartan Sales by Country (2021-2026)
  4. 7.1.3 North America Telmisartan Sales Forecast by Country (2027-2032)
  5. 7.2 North America Telmisartan Market Size by Country
  6. 7.2.1 North America Telmisartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Telmisartan Market Size by Country (2021-2026)
  8. 7.2.3 North America Telmisartan Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Telmisartan Sales by Country
  2. 8.1.1 Europe Telmisartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Telmisartan Sales by Country (2021-2026)
  4. 8.1.3 Europe Telmisartan Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Telmisartan Market Size by Country
  6. 8.2.1 Europe Telmisartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Telmisartan Market Size by Country (2021-2026)
  8. 8.2.3 Europe Telmisartan Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Telmisartan Sales by Country
  2. 9.1.1 Asia-Pacific Telmisartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Telmisartan Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Telmisartan Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Telmisartan Market Size by Country
  6. 9.2.1 Asia-Pacific Telmisartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Telmisartan Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Telmisartan Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Telmisartan Sales by Country
  2. 10.1.1 South America Telmisartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Telmisartan Sales by Country (2021-2026)
  4. 10.1.3 South America Telmisartan Sales Forecast by Country (2027-2032)
  5. 10.2 South America Telmisartan Market Size by Country
  6. 10.2.1 South America Telmisartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Telmisartan Market Size by Country (2021-2026)
  8. 10.2.3 South America Telmisartan Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Telmisartan Sales by Country
  2. 11.1.1 Middle East and Africa Telmisartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Telmisartan Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Telmisartan Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Telmisartan Market Size by Country
  6. 11.2.1 Middle East and Africa Telmisartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Telmisartan Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Telmisartan Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Telmisartan Value Chain Analysis
  2. 12.1.1 Telmisartan Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Telmisartan Production Mode & Process
  7. 12.2 Telmisartan Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Telmisartan Distributors
  10. 12.2.3 Telmisartan Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst